New York, NY, United States of America

Douglas N Mintz

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas N Mintz. Retrieved from https://idiyas.com/inventor/douglas-n-mintz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Douglas N Mintz

Introduction

Douglas N Mintz is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of lipopolysaccharide (LPS) binding. His work has implications for understanding various biological processes and potential therapeutic interventions.

Latest Patents

Douglas N Mintz holds a patent titled "Methods for identifying inhibitors of LPS-mediated LBP binding." This invention describes a rapid method for identifying compounds or reagents that inhibit LPS binding to LPS binding protein (LBP). Additionally, it includes kits designed for practicing this method. He has 1 patent to his name.

Career Highlights

Douglas is affiliated with the Scripps Research Institute, where he continues to engage in innovative research. His work is pivotal in advancing our understanding of immune responses and developing new therapeutic strategies.

Collaborations

He has collaborated with esteemed colleagues such as Peter S Tobias and Richard J Ulevitch, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Douglas N Mintz exemplifies the spirit of innovation in the field of biomedical research. His contributions through patents and collaborations highlight the importance of scientific advancement in understanding complex biological systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…